These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8358989)

  • 21. Sneddon's syndrome with anticardiolipin antibodies--complications and treatment.
    Lotz BP; Schutte CM; Colin PF; Biermann LD
    S Afr Med J; 1993 Sep; 83(9):663-4. PubMed ID: 8310361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of anti-endothelial cell antibodies in patients with Sneddon's syndrome.
    Francès C; Le Tonquèze M; Salohzin KV; Kalashnikova LA; Piette JC; Godeau P; Nasonov EL; Youinou P
    J Am Acad Dermatol; 1995 Jul; 33(1):64-8. PubMed ID: 7601948
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sneddon's syndrome, anti-cardiolipin antibody and glomerular thrombosis.
    Stevens JM; Hunt JE; Seymour AE; Krilis SA; Pugsley DJ
    Clin Nephrol; 1994 Jan; 41(1):18-22. PubMed ID: 8137565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Livedo reticularis and cerebrovascular accidents (Sneddon's syndrome) as a clinical expression of antiphospholipid syndrome.
    Gantcheva M; Tsankov N
    J Eur Acad Dermatol Venereol; 1999 Mar; 12(2):157-60. PubMed ID: 10343946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Classification of Sneddon's syndrome.
    Schellong SM; Weissenborn K; Niedermeyer J; Wollenhaupt J; Sosada M; Ehrenheim C; Lubach D
    Vasa; 1997 Aug; 26(3):215-21. PubMed ID: 9286155
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A combination of livedo racemosa, occlusion of cerebral blood vessels, and nephropathy: kidney involvement in Sneddon's syndrome.
    Ohtani H; Imai H; Yasuda T; Wakui H; Komatsuda A; Hamai K; Miura AB
    Am J Kidney Dis; 1995 Sep; 26(3):511-5. PubMed ID: 7645561
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cerebrovascular disorders associated with livedo (Sneddon's syndrome): its relation to lupus anticoagulant].
    Kalashnikova LA; Prudnikova LZ; Nasonov EP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(7):104-7. PubMed ID: 2175072
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Sneddon syndrome].
    Richard MA; Grob JJ; Durand JM; Noë C; Basseres N; Bonerandi JJ
    Ann Dermatol Venereol; 1994; 121(4):331-7. PubMed ID: 7702255
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Sneddon's syndrome: its clinical characteristics and etiopathogenic factors].
    Sempere AP; Martínez B; Bermejo F; Tahoces ML; Cabello A
    Rev Clin Esp; 1992 Jun; 191(1):3-7. PubMed ID: 1631358
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term course of antiphospholipid-antibody-negative Sneddon's syndrome.
    Kraemer M; Berlit P
    Clin Neurol Neurosurg; 2008 Dec; 110(10):1072. PubMed ID: 18603355
    [No Abstract]   [Full Text] [Related]  

  • 31. [Definition of Sneddon's syndrome: a network of convolutions].
    Francès C; Piette JC
    Ann Dermatol Venereol; 1994; 121(4):293-6. PubMed ID: 7702246
    [No Abstract]   [Full Text] [Related]  

  • 32. Sneddon's syndrome: clinical and immunohistochemical findings.
    Fetoni V; Berti E; Cecca E; Carella F; Sinico RA; Girotti F
    Clin Neurol Neurosurg; 1994 Nov; 96(4):310-3. PubMed ID: 7889693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Livedo reticularis, cerebrovascular disorders and mitral disease: a new cause of Sneddon's syndrome?].
    Vaillant L; Larmande P; Arbeille B; Desveaux B; Gruel Y; Lorette G
    Ann Dermatol Venereol; 1990; 117(12):925-30. PubMed ID: 2082786
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sneddon's syndrome: generalized livedo reticularis and cerebrovascular disease. Importance of hemostatic screening.
    Devos J; Bulcke J; Degreef H; Michielsen B
    Dermatology; 1992; 185(4):296-9. PubMed ID: 1477426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anticardiolipin antibodies in Sneddon's syndrome.
    Kalashnikova LA; Nasonov EL; Kushekbaeva AE; Gracheva LA
    Neurology; 1990 Mar; 40(3 Pt 1):464-7. PubMed ID: 2314589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cutaneous manifestations of antiphospholipid antibody syndrome.
    Weinstein S; Piette W
    Hematol Oncol Clin North Am; 2008 Feb; 22(1):67-77, vi. PubMed ID: 18207066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A clinical case of Sneddon's disease].
    Gudueva FI; Belokrinitskiĭ DV
    Ter Arkh; 1992; 64(4):103-4. PubMed ID: 1440290
    [No Abstract]   [Full Text] [Related]  

  • 38. Sneddon's syndrome. A long-term follow-up of 21 patients.
    Zelger B; Sepp N; Stockhammer G; Dosch E; Hilty E; Ofner D; Aichner F; Fritsch PO
    Arch Dermatol; 1993 Apr; 129(4):437-47. PubMed ID: 8466214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Sneddon's syndrome: apropos a case].
    Cuadrado-Gómez LM; Arranz-Caso A; Martín-Llorens M; Arribalzaga K
    Rev Clin Esp; 1993 Feb; 192(3):151-2. PubMed ID: 8465057
    [No Abstract]   [Full Text] [Related]  

  • 40. Sneddon's syndrome and primary antiphospholipid syndrome: a case report.
    Manganelli P; Lisi R; Saginario A; Benoldi D
    J Am Acad Dermatol; 1992 Feb; 26(2 Pt 2):309-11. PubMed ID: 1569247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.